Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.
Document Type
Article
Publication Date
6-2025
Publication Title
JACC. Heart failure
Volume
13
Issue
6
First Page
1037
Last Page
1040
Recommended Citation
Desai MY, Saberi S, Geske JB, Wang A, Cremer P, Fermin DR et al Long-term response of obstructive hypertrophic cardiomyopathy patients to mavacamten based on sex: insights from the VALOR-HCM Trial. JACC Heart Fail. 2025 Jun;13(6):1037-1040. doi: 10.1016/j.jchf.2025.02.005. Epub 2025 Mar 17. PMID: 40100181.
DOI
10.1016/j.jchf.2025.02.005
ISSN
2213-1787
PubMed ID
40100181
COinS